CRISPR Delivery in the Ear

Antonio Regalado, MIT Technology Review, 22 September 2017,

One of the major challenges with CRISPR based medical therapies is delivering the necessary components.  One group at the Massachusetts Eye and Ear Infirmary are working on delivering the CRISPR/Cas machinery into mice ears to cure a genetic defect that results in gradual hearing loss.  In the best cases the mice retained significant hearing at two months of age.

Author: Advanced Analytical

Advanced Analytical Technologies, Inc. (AATI) simplifies complex genomics workflows to accelerate research and discovery in pharmaceuticals, life science, biofuels, biotechnology and healthcare.

Leave a Reply